Literature DB >> 25342390

Do environmental factors modify the genetic risk of prostate cancer?

Stacy Loeb1, Sarah B Peskoe2, Corinne E Joshu2, Wen-Yi Huang3, Richard B Hayes4, H Ballentine Carter5, William B Isaacs5, Elizabeth A Platz6.   

Abstract

BACKGROUND: Many SNPs influence prostate cancer risk. To what extent genetic risk can be reduced by environmental factors is unknown.
METHODS: We evaluated effect modification by environmental factors of the association between susceptibility SNPs and prostate cancer in 1,230 incident prostate cancer cases and 1,361 controls, all white and similar ages, nested in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Trial. Genetic risk scores were calculated as number of risk alleles for 20 validated SNPs. We estimated the association between higher genetic risk (≥12 SNPs) and prostate cancer within environmental factor strata and tested for interaction.
RESULTS: Men with ≥12 risk alleles had 1.98, 2.04, and 1.91 times the odds of total, advanced, and nonadvanced prostate cancer, respectively. These associations were attenuated with the use of selenium supplements, aspirin, ibuprofen, and higher vegetable intake. For selenium, the attenuation was most striking for advanced prostate cancer: compared with <12 alleles and no selenium, the OR for ≥12 alleles was 2.06 [95% confidence interval (CI), 1.67-2.55] in nonusers and 0.99 (0.38-2.58) in users (Pinteraction = 0.031). Aspirin had the most marked attenuation for nonadvanced prostate cancer: compared with <12 alleles and nonusers, the OR for ≥12 alleles was 2.25 (1.69-3.00) in nonusers and 1.70 (1.25-2.32) in users (Pinteraction = 0.009). This pattern was similar for ibuprofen (Pinteraction = 0.023) and vegetables (Pinteraction = 0.010).
CONCLUSIONS: This study suggests that selenium supplements may reduce genetic risk of advanced prostate cancer, whereas aspirin, ibuprofen, and vegetables may reduce genetic risk of nonadvanced prostate cancer. IMPACT: The effect of genetic factors on prostate cancer risk may vary by lifestyle interventions. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2014        PMID: 25342390      PMCID: PMC4337874          DOI: 10.1158/1055-9965.EPI-14-0786-T

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  33 in total

1.  A common variant associated with prostate cancer in European and African populations.

Authors:  Laufey T Amundadottir; Patrick Sulem; Julius Gudmundsson; Agnar Helgason; Adam Baker; Bjarni A Agnarsson; Asgeir Sigurdsson; Kristrun R Benediktsdottir; Jean-Baptiste Cazier; Jesus Sainz; Margret Jakobsdottir; Jelena Kostic; Droplaug N Magnusdottir; Shyamali Ghosh; Kari Agnarsson; Birgitta Birgisdottir; Louise Le Roux; Adalheidur Olafsdottir; Thorarinn Blondal; Margret Andresdottir; Olafia Svandis Gretarsdottir; Jon T Bergthorsson; Daniel Gudbjartsson; Arnaldur Gylfason; Gudmar Thorleifsson; Andrei Manolescu; Kristleifur Kristjansson; Gudmundur Geirsson; Helgi Isaksson; Julie Douglas; Jan-Erik Johansson; Katarina Bälter; Fredrik Wiklund; James E Montie; Xiaoying Yu; Brian K Suarez; Carole Ober; Kathleen A Cooney; Henrik Gronberg; William J Catalona; Gudmundur V Einarsson; Rosa B Barkardottir; Jeffrey R Gulcher; Augustine Kong; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  Nat Genet       Date:  2006-05-07       Impact factor: 38.330

2.  Serum selenium and risk of prostate cancer-a nested case-control study.

Authors:  Ulrike Peters; Charles B Foster; Nilanjan Chatterjee; Arthur Schatzkin; Douglas Reding; Gerald L Andriole; E David Crawford; Stefan Sturup; Stephen J Chanock; Richard B Hayes
Journal:  Am J Clin Nutr       Date:  2007-01       Impact factor: 7.045

3.  Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland.

Authors:  P Lichtenstein; N V Holm; P K Verkasalo; A Iliadou; J Kaprio; M Koskenvuo; E Pukkala; A Skytthe; K Hemminki
Journal:  N Engl J Med       Date:  2000-07-13       Impact factor: 91.245

4.  Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.

Authors:  L C Clark; G F Combs; B W Turnbull; E H Slate; D K Chalker; J Chow; L S Davis; R A Glover; G F Graham; E G Gross; A Krongrad; J L Lesher; H K Park; B B Sanders; C L Smith; J R Taylor
Journal:  JAMA       Date:  1996-12-25       Impact factor: 56.272

Review 5.  Brassica vegetables and prostate cancer risk: a review of the epidemiological evidence.

Authors:  Alan R Kristal; Johanna W Lampe
Journal:  Nutr Cancer       Date:  2002       Impact factor: 2.900

6.  Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial.

Authors:  A J Duffield-Lillico; B L Dalkin; M E Reid; B W Turnbull; E H Slate; E T Jacobs; J R Marshall; L C Clark
Journal:  BJU Int       Date:  2003-05       Impact factor: 5.588

7.  A genetic score can identify men at high risk for prostate cancer among men with prostate-specific antigen of 1-3 ng/ml.

Authors:  Tobias Nordström; Markus Aly; Martin Eklund; Lars Egevad; Henrik Grönberg
Journal:  Eur Urol       Date:  2013-07-19       Impact factor: 20.096

8.  The influence of finasteride on the development of prostate cancer.

Authors:  Ian M Thompson; Phyllis J Goodman; Catherine M Tangen; M Scott Lucia; Gary J Miller; Leslie G Ford; Michael M Lieber; R Duane Cespedes; James N Atkins; Scott M Lippman; Susie M Carlin; Anne Ryan; Connie M Szczepanek; John J Crowley; Charles A Coltman
Journal:  N Engl J Med       Date:  2003-06-24       Impact factor: 91.245

9.  A prospective study of cruciferous vegetables and prostate cancer.

Authors:  Edward Giovannucci; Eric B Rimm; Yan Liu; Meir J Stampfer; Walter C Willett
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-12       Impact factor: 4.254

10.  Multiple loci identified in a genome-wide association study of prostate cancer.

Authors:  Gilles Thomas; Kevin B Jacobs; Meredith Yeager; Peter Kraft; Sholom Wacholder; Nick Orr; Kai Yu; Nilanjan Chatterjee; Robert Welch; Amy Hutchinson; Andrew Crenshaw; Geraldine Cancel-Tassin; Brian J Staats; Zhaoming Wang; Jesus Gonzalez-Bosquet; Jun Fang; Xiang Deng; Sonja I Berndt; Eugenia E Calle; Heather Spencer Feigelson; Michael J Thun; Carmen Rodriguez; Demetrius Albanes; Jarmo Virtamo; Stephanie Weinstein; Fredrick R Schumacher; Edward Giovannucci; Walter C Willett; Olivier Cussenot; Antoine Valeri; Gerald L Andriole; E David Crawford; Margaret Tucker; Daniela S Gerhard; Joseph F Fraumeni; Robert Hoover; Richard B Hayes; David J Hunter; Stephen J Chanock
Journal:  Nat Genet       Date:  2008-02-10       Impact factor: 38.330

View more
  5 in total

1.  Defining the Impact of Family History on Detection of High-grade Prostate Cancer in a Large Multi-institutional Cohort.

Authors:  Matthew B Clements; Emily A Vertosick; Lourdes Guerrios-Rivera; Amanda M De Hoedt; Javier Hernandez; Michael A Liss; Robin J Leach; Stephen J Freedland; Alexander Haese; Francesco Montorsi; Stephen A Boorjian; Cedric Poyet; Donna P Ankerst; Andrew J Vickers
Journal:  Eur Urol       Date:  2021-12-31       Impact factor: 24.267

Review 2.  Selenium for preventing cancer.

Authors:  Marco Vinceti; Tommaso Filippini; Cinzia Del Giovane; Gabriele Dennert; Marcel Zwahlen; Maree Brinkman; Maurice Pa Zeegers; Markus Horneber; Roberto D'Amico; Catherine M Crespi
Journal:  Cochrane Database Syst Rev       Date:  2018-01-29

3.  The Cumulative Effect of Gene-Gene and Gene-Environment Interactions on the Risk of Prostate Cancer in Chinese Men.

Authors:  Ming Liu; Xiaohong Shi; Fan Yang; Jianye Wang; Yong Xu; Dong Wei; Kuo Yang; Yaoguang Zhang; Xin Wang; Siying Liang; Xin Chen; Liang Sun; Xiaoquan Zhu; Chengxiao Zhao; Ling Zhu; Lei Tang; Chenguang Zheng; Ze Yang
Journal:  Int J Environ Res Public Health       Date:  2016-01-27       Impact factor: 3.390

4.  Different spatial pattern of municipal prostate cancer mortality in younger men in Spain.

Authors:  Lara Rodriguez-Sanchez; Pablo Fernández-Navarro; Gonzalo López-Abente; Olivier Nuñez; Nerea Fernández de Larrea-Baz; Jose Juan Jimenez-Moleón; Álvaro Páez Borda; Marina Pollán; Beatriz Perez-Gomez
Journal:  PLoS One       Date:  2019-01-25       Impact factor: 3.240

5.  Integrated analysis of miRNA landscape and cellular networking pathways in stage-specific prostate cancer.

Authors:  Shiv Verma; Mitali Pandey; Girish C Shukla; Vaibhav Singh; Sanjay Gupta
Journal:  PLoS One       Date:  2019-11-22       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.